Impact of the COVID-19 Pandemic on Treatment Patterns for Patients With Metastatic Solid Cancer in the United States
Parikh RB, Takvorian SU, Vader D, Wileyto E, Clark AS, Lee DJ, Goyal G, Rocque GB, Dotan E, Geynisman DM, Phull P, Spiess PE, Kim RY, Davidoff AJ, Gross CP, Neparidze N, Miksad RA, Calip GS, Hearn CM, Ferrell W, Shulman LN, Mamtani R, Hubbard RA, Investigators T. Impact of the COVID-19 Pandemic on Treatment Patterns for Patients With Metastatic Solid Cancer in the United States. Journal Of The National Cancer Institute 2021, 114: 571-578. PMID: 34893865, PMCID: PMC9002283, DOI: 10.1093/jnci/djab225.Peer-Reviewed Original ResearchMeSH KeywordsCOVID-19HumansNeoplasm Recurrence, LocalNeoplasms, Second PrimaryPandemicsTime-to-TreatmentUnited StatesConceptsMetastatic solid cancersFirst-line systemic therapyTreatment initiationSolid cancersSystemic therapyTreatment patternsMyelosuppressive therapyTreatment selectionCommunity-based oncology practicesCOVID-19 pandemicTechnology-enabled abstractionDays of diagnosisLife-threatening conditionInterrupted time series analysisMetastatic diagnosisUS patientsEffect modificationOncology practiceMetastatic cancerAdjusted probabilityPatientsPandemic periodPandemic-related delaysTherapyCancer